Phocas Financial’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding BCRX
JHC
Phocas Financial's BCRX Position: Q3 2026 in Review
Phocas Financial sold out of BioCryst Pharmaceuticals (BCRX) in Q3 2026, closing a stake of 340,541 shares — an estimated $3.41M sold.
Phocas Financial first reported a position in BCRX in Q4 2025 and held it in 3 quarters. The position peaked at $3.41M in Q2 2026. 241 funds tracked by Wall St. Rank hold BCRX as of Q3 2026.
- Phocas Financial reported no remaining BioCryst Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Phocas Financial sold 340,541 BioCryst Pharmaceuticals shares in Q3 2026, an estimated $3.41M.
- Phocas Financial first reported a position in BioCryst Pharmaceuticals in Q4 2025 and held it in 3 quarters.
- Phocas Financial's BioCryst Pharmaceuticals position peaked at $3.41M in Q2 2026.
- 241 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q3 2026.
Based on Phocas Financial's 13F filing for Q3 2026.